SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sequenom, Inc. (SQNM)
An SI Board Since January 2000
Posts SubjectMarks Bans Symbol
364 54 0 SQNM
Emcee:  Nav Toor Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
89SEQUENOM Enhances Leadership Position With Eight Additional MassARRAY(TM) Systemnigel bates-1/11/2002
88<``We are pleased to form this relationship with HiberGen and eager to explorsmh-1/5/2002
87Plant, Animal and Microbe Genomes X Conference January 12 - 16, 2002 Town &2bstealthy-1/1/2002
86total of 32 patents... PAT. NO. Title 1 6,322,970 Mass spectrometric detectio2bstealthy-1/1/2002
85New SQNM patent... United States Patent 6,322,970 Little , et al. November 272bstealthy-1/1/2002
84Unclear to me if SQNM derives any benefit from this, but looks interesting: >tuck-12/19/2001
83SAN DIEGO, Dec. 10 /PRNewswire/ -- SEQUENOM(TM), Inc. (Nasdaq: SQNM - news), a dnigel bates-12/10/2001
82SEQUENOM Receives $2.2 Million Grant From NIH For Genome-Wide Disease Associationigel bates-11/9/2001
81SAN DIEGO, Calif. and BILLERICA, Mass.--(BW HealthWire)--Nov. 5, 2001-- GenoFlexnigel bates-11/5/2001
80<i>For a (mostly) market-immune, biotech that's on track with their plnigel bates-11/2/2001
79Does anyone here have any experience with trading behavior prior to and after efLawrence Burg-11/1/2001
78SEQUENOM Provides Two-Year Strategic Plan and Financial Guidance SAN DIEGO, Novnigel bates-11/1/2001
77SEQUENOM Completes Collaboration With FDA, Resulting in a Faster Method For Advanigel bates-10/25/2001
76A not unreasonable reaction to the current shareprice - SAN DIEGO, Oct. 22 /PRNnigel bates-10/22/2001
75SAN DIEGO, Oct. 2 /PRNewswire/ -- SEQUENOM(TM), Inc. (Nasdaq: SQNM - news) todaynigel bates-10/2/2001
74SEQUENOM Completes Merger With Gemini Genomics SAN DIEGO, Sept. 20 /PRNewswire/nigel bates-9/20/2001
73Bought a few more today, FWIW. Interesting interview with Paul Kelly on the mergnigel bates-9/7/2001
72Message 16304260nigel bates-9/6/2001
71SEQUENOM and GlaxoSmithKline Join Forces to Generate Genome-Wide SNP Assay Portfnigel bates-8/29/2001
70>>CAMBRIDGE, United Kingdom--(BW HealthWire)--August 28, 2001--Gemini Genotuck-8/29/2001
69SEQUENOM Shareholders Approve Merger With Gemini Genomics SAN DIEGO, Aug. 23 /Pnigel bates-8/24/2001
68EQUENOM Sells Five Additional MassARRAY(TM) Systems, Raising Total for Second Qunigel bates-7/10/2001
67DUBLIN, Ireland and SAN DIEGO, July 9 /PRNewswire/ -- HiberGen Limited, the Irisnigel bates-7/9/2001
66CAMBRIDGE, U.K.--(BW HealthWire)--June 27, 2001--Gemini Genomics plc (Nasdaq:GMNnigel bates-6/27/2001
65SAN DIEGO, June 19 /PRNewswire/ -- SEQUENOM(TM), Inc. (Nasdaq: SQNM - news) todanigel bates-6/19/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News